Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine.
Haoqiang Lai, Ligeng Xu, Chang Liu, Sujiang Shi, Yalin Jiang, Yangyang Yu, Bo Deng, Tianfeng Chen
Author Information
- Haoqiang Lai: Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
- Ligeng Xu: Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China. lgxu19@jnu.edu.cn.
- Chang Liu: Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
- Sujiang Shi: Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
- Yalin Jiang: Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
- Yangyang Yu: Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
- Bo Deng: Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China.
- Tianfeng Chen: Department of Oncology, The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou, 510632, China. tchentf@jnu.edu.cn. ORCID
No abstract text available.
- Cell Metab. 2020 Sep 1;32(3):457-467.e5
[PMID: 32738204]
- Nat Rev Immunol. 2021 Jun;21(6):363-381
[PMID: 33340021]
- ACS Nano. 2020 Sep 22;14(9):11067-11082
[PMID: 32806028]
- Cell Rep. 2021 Mar 16;34(11):108863
[PMID: 33691089]
- Nat Immunol. 2021 Sep;22(9):1127-1139
[PMID: 34413521]
Humans
Selenium
COVID-19 Vaccines
COVID-19
SARS-CoV-2
Oxidation-Reduction
Selenium
COVID-19 Vaccines
